Cost Assessment of Antiretroviral Drugs Used in the Treatment of Patients with HIV Infection: Focus on Non-Nucleoside Reverse Transcriptase Inhibitors

Author： Sabbatani S.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.22, Iss.4, 2002-01, pp. : 253-262

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Non-Nucleoside Reverse Transcriptase Inhibitors in Children with HIV-1 Infection

By Maddocks S.   Dwyer D.  

Pediatric Drugs, Vol. 3, Iss. 9, 2001-01 ,pp. : 681-702

Adis International

Access to resources Recommend Favorite

Non-nucleoside reverse transcriptase inhibitors: perspectives on novel therapeutic compounds and strategies for the treatment of HIV infection

By Buckheit Robert W  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 8, 2001-08 ,pp. : 1423-1442

Informa Healthcare

Access to resources Recommend Favorite

Non-nucleoside inhibitors of HIV-1 reverse transcriptase

By Proudfoot J.R.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 8, 1998-08 ,pp. : 971-982

Informa Healthcare

Access to resources Recommend Favorite

HIV-1 non-nucleoside reverse transcriptase inhibitors

By Högberg M.   Morrison I.  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 8, 2000-08 ,pp. : 1189-1199

Informa Healthcare

Access to resources Recommend Favorite

The Emerging Roles of Non-Nucleoside Reverse Transcriptase Inhibitors in Antiretroviral Therapy

By Moyle G.  

Drugs, Vol. 61, Iss. 1, 2001-01 ,pp. : 19-26

Adis International

Access to resources Recommend Favorite